Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1993 Feb;108(2):304–311. doi: 10.1111/j.1476-5381.1993.tb12800.x

Localization and characterization of neuropeptide Y binding sites in porcine and human colon.

D A Walsh 1, J Wharton 1, D R Blake 1, J M Polak 1
PMCID: PMC1908005  PMID: 8448582

Abstract

1. We have used quantitative receptor autoradiography to investigate the localization and characteristics of binding sites for 125Iodine-Bolton Hunter-labelled human neuropeptide Y ([125I]-BH-NPY) in porcine and human colon, and compared the binding characteristics with those found in porcine spleen. 2. Saturable, specific, high affinity [125I]-BH-NPY binding was localized to myenteric ganglia in porcine and human colons, and to submucosal ganglia in porcine colon. 3. Specific [125I]-BH-NPY binding to porcine myenteric ganglia was reversible in the presence of guanosine 5'-O-(3-thiotriphosphate) and was inhibited by related peptides with the rank order of potency; porcine NPY = human NPY = peptide tyrosine tyrosine (PYY) >> pancreatic polypeptide. 4. The Y2 selective analogue, NPY (13-36), competed for [125I]-BH-NPY binding to porcine myenteric ganglia with greater potency than the Y1 selective analogue, [Leu31, Pro34] NPY, the difference being small, but significant. 5. The characteristics of [125I]-BH-NPY binding to porcine myenteric ganglia were similar to those observed concurrently to porcine splenic red pulp. 6. The small difference in inhibitory potencies between NPY(13-36) and [Leu31, Pro34]NPY observed in this study in comparison with previous studies was not explained by differential ligand depletion during incubations, but may be due to differences in methodology between binding studies performed on tissue sections and on membranes. 7. We conclude that specific [25I]-BH-NPY binding sites are present in the myenteric and submucosal ganglia of the colon and that these sites may act as functional receptors by which NPY and PYY modulate colonic motility and electrolyte transport.

Full text

PDF

Images in this article

306Figure 1
on p.306
307Figure 2
on p.307

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adrian T. E., Ferri G. L., Bacarese-Hamilton A. J., Fuessl H. S., Polak J. M., Bloom S. R. Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology. 1985 Nov;89(5):1070–1077. doi: 10.1016/0016-5085(85)90211-2. [DOI] [PubMed] [Google Scholar]
  2. Allen J. M., Hughes J., Bloom S. R. Presence, distribution, and pharmacological effects of neuropeptide Y in mammalian gastrointestinal tract. Dig Dis Sci. 1987 May;32(5):506–512. doi: 10.1007/BF01296034. [DOI] [PubMed] [Google Scholar]
  3. Andriantsitohaina R., Stoclet J. C. Enhancement by neuropeptide Y (NPY) of the dihydropyridine-sensitive component of the response to alpha 1-adrenoceptor stimulation in rat isolated mesenteric arterioles. Br J Pharmacol. 1990 Feb;99(2):389–395. doi: 10.1111/j.1476-5381.1990.tb14714.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cox H. M., Cuthbert A. W., Håkanson R., Wahlestedt C. The effect of neuropeptide Y and peptide YY on electrogenic ion transport in rat intestinal epithelia. J Physiol. 1988 Apr;398:65–80. doi: 10.1113/jphysiol.1988.sp017029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. El-Badawi A., Schenk E. A. Histochemical methods for separate, consecutive and simultaneous demonstration of acetylcholinesterase and norepinephrine in cryostat sections. J Histochem Cytochem. 1967 Oct;15(10):580–588. doi: 10.1177/15.10.580. [DOI] [PubMed] [Google Scholar]
  6. Fuhlendorff J., Gether U., Aakerlund L., Langeland-Johansen N., Thøgersen H., Melberg S. G., Olsen U. B., Thastrup O., Schwartz T. W. [Leu31, Pro34]neuropeptide Y: a specific Y1 receptor agonist. Proc Natl Acad Sci U S A. 1990 Jan;87(1):182–186. doi: 10.1073/pnas.87.1.182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Furness J. B., Costa M., Emson P. C., Håkanson R., Moghimzadeh E., Sundler F., Taylor I. L., Chance R. E. Distribution, pathways and reactions to drug treatment of nerves with neuropeptide Y- and pancreatic polypeptide-like immunoreactivity in the guinea-pig digestive tract. Cell Tissue Res. 1983;234(1):71–92. doi: 10.1007/BF00217403. [DOI] [PubMed] [Google Scholar]
  8. Greeley G. H., Jr, Jeng Y. J., Gomez G., Hashimoto T., Hill F. L., Kern K., Kurosky T., Chuo H. F., Thompson J. C. Evidence for regulation of peptide-YY release by the proximal gut. Endocrinology. 1989 Mar;124(3):1438–1443. doi: 10.1210/endo-124-3-1438. [DOI] [PubMed] [Google Scholar]
  9. Hellström P. M., Lundberg J. M., Hökfelt T., Goldstein M. Neuropeptide Y, peptide YY, and sympathetic control of rectal tone and anal canal pressure in the cat. Scand J Gastroenterol. 1989 Mar;24(2):231–243. doi: 10.3109/00365528909093041. [DOI] [PubMed] [Google Scholar]
  10. Hellström P. M. Mechanisms involved in colonic vasoconstriction and inhibition of motility induced by neuropeptide Y. Acta Physiol Scand. 1987 Apr;129(4):549–556. doi: 10.1111/j.1748-1716.1987.tb08096.x. [DOI] [PubMed] [Google Scholar]
  11. Hellström P. M., Olerup O., Tatemoto K. Neuropeptide Y may mediate effects of sympathetic nerve stimulations on colonic motility and blood flow in the cat. Acta Physiol Scand. 1985 Aug;124(4):613–624. doi: 10.1111/j.1748-1716.1985.tb00055.x. [DOI] [PubMed] [Google Scholar]
  12. Herzog H., Hort Y. J., Ball H. J., Hayes G., Shine J., Selbie L. A. Cloned human neuropeptide Y receptor couples to two different second messenger systems. Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):5794–5798. doi: 10.1073/pnas.89.13.5794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hirning L. D., Fox A. P., Miller R. J. Inhibition of calcium currents in cultured myenteric neurons by neuropeptide Y: evidence for direct receptor/channel coupling. Brain Res. 1990 Nov 5;532(1-2):120–130. doi: 10.1016/0006-8993(90)91751-2. [DOI] [PubMed] [Google Scholar]
  14. Larhammar D., Blomqvist A. G., Yee F., Jazin E., Yoo H., Wahlested C. Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type. J Biol Chem. 1992 Jun 5;267(16):10935–10938. [PubMed] [Google Scholar]
  15. Leys K., Schachter M., Sever P. Autoradiographic localisation of NPY receptors in rabbit kidney: comparison with rat, guinea-pig and human. Eur J Pharmacol. 1987 Feb 10;134(2):233–237. doi: 10.1016/0014-2999(87)90171-3. [DOI] [PubMed] [Google Scholar]
  16. Lundberg J. M., Hemsén A., Larsson O., Rudehill A., Saria A., Fredholm B. B. Neuropeptide Y receptor in pig spleen: binding characteristics, reduction of cyclic AMP formation and calcium antagonist inhibition of vasoconstriction. Eur J Pharmacol. 1988 Jan 5;145(1):21–29. doi: 10.1016/0014-2999(88)90344-5. [DOI] [PubMed] [Google Scholar]
  17. Lundberg J. M., Hemsén A., Rudehill A., Härfstrand A., Larsson O., Sollevi A., Saria A., Hökfelt T., Fuxe K., Fredholm B. B. Neuropeptide Y- and alpha-adrenergic receptors in pig spleen: localization, binding characteristics, cyclic AMP effects and functional responses in control and denervated animals. Neuroscience. 1988 Feb;24(2):659–672. doi: 10.1016/0306-4522(88)90359-4. [DOI] [PubMed] [Google Scholar]
  18. Lundberg J. M., Tatemoto K., Terenius L., Hellström P. M., Mutt V., Hökfelt T., Hamberger B. Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility. Proc Natl Acad Sci U S A. 1982 Jul;79(14):4471–4475. doi: 10.1073/pnas.79.14.4471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Modin A., Pernow J., Lundberg J. M. Evidence for two neuropeptide Y receptors mediating vasoconstriction. Eur J Pharmacol. 1991 Oct 15;203(2):165–171. doi: 10.1016/0014-2999(91)90711-x. [DOI] [PubMed] [Google Scholar]
  20. Nguyen T. D., Heintz G. G., Kaiser L. M., Staley C. A., Taylor I. L. Neuropeptide Y. Differential binding to rat intestinal laterobasal membranes. J Biol Chem. 1990 Apr 15;265(11):6416–6422. [PubMed] [Google Scholar]
  21. Okuno M., Nakanishi T., Shinomura Y., Kiyohara T., Ishikawa H., Tarui S. Peptide YY enhances NaCl and water absorption in the rat colon in vivo. Experientia. 1992 Jan 15;48(1):47–50. doi: 10.1007/BF01923605. [DOI] [PubMed] [Google Scholar]
  22. Rimland J., Xin W., Sweetnam P., Saijoh K., Nestler E. J., Duman R. S. Sequence and expression of a neuropeptide Y receptor cDNA. Mol Pharmacol. 1991 Dec;40(6):869–875. [PubMed] [Google Scholar]
  23. Sheikh S. P. Neuropeptide Y and peptide YY: major modulators of gastrointestinal blood flow and function. Am J Physiol. 1991 Nov;261(5 Pt 1):G701–G715. doi: 10.1152/ajpgi.1991.261.5.G701. [DOI] [PubMed] [Google Scholar]
  24. Tatemoto K., Carlquist M., Mutt V. Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature. 1982 Apr 15;296(5858):659–660. doi: 10.1038/296659a0. [DOI] [PubMed] [Google Scholar]
  25. Taylor I. L. Distribution and release of peptide YY in dog measured by specific radioimmunoassay. Gastroenterology. 1985 Mar;88(3):731–737. doi: 10.1016/0016-5085(85)90144-1. [DOI] [PubMed] [Google Scholar]
  26. Wahlestedt C., Grundemar L., Håkanson R., Heilig M., Shen G. H., Zukowska-Grojec Z., Reis D. J. Neuropeptide Y receptor subtypes, Y1 and Y2. Ann N Y Acad Sci. 1990;611:7–26. doi: 10.1111/j.1749-6632.1990.tb48918.x. [DOI] [PubMed] [Google Scholar]
  27. Westfall T. C., Carpentier S., Chen X., Beinfeld M. C., Naes L., Meldrum M. J. Prejunctional and postjunctional effects of neuropeptide Y at the noradrenergic neuroeffector junction of the perfused mesenteric arterial bed of the rat. J Cardiovasc Pharmacol. 1987 Dec;10(6):716–722. doi: 10.1097/00005344-198712000-00016. [DOI] [PubMed] [Google Scholar]
  28. Wiley J., Owyang C. Neuropeptide Y inhibits cholinergic transmission in the isolated guinea pig colon: mediation through alpha-adrenergic receptors. Proc Natl Acad Sci U S A. 1987 Apr;84(7):2047–2051. doi: 10.1073/pnas.84.7.2047. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES